AI generated summary of Pubmed citation/abstract with PMID 38091841

https://pubmed.ncbi.nlm.nih.gov/38091841

Astragaloside IV alleviates lipopolysaccharide-induced cardiomyocyte hypertrophy and fibrosis through CCL2-mediated inhibition of the NF-κB signaling pathway, providing a scientific basis for its potential in heart failure treatment.